Theravance Biopharma Inc

TBPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.05

+$0.03 (+0.18%)

At close: Sep 21, 2026, 4:00 PM ET

$17.05

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	105.9M	-56.42M	-55.19M	-92.82M	-265.07M	-294.82M
Depreciation & Amortization	5.64M	3.62M	4.26M	7.02M	8.6M	6.97M
Stock-Based Compensation	18.48M	21.39M	25.37M	39.73M	62.06M	62.98M
Other Working Capital	147.24M	20.57M	-7.66M	46.68M	-37.82M	-47.56M
Other Non-Cash Items	-423K	7.09M	3.7M	-183.28M	26.1M	12.25M
Deferred Income Tax	-11.52M	-7.57M	3.21M	n/a	n/a	n/a
Change in Working Capital	120.47M	20.36M	-8.34M	42.35M	-39.55M	-37.78M
Operating Cash Flow	238.54M	-11.54M	-27M	-186.99M	-207.86M	-250.4M
Capital Expenditures	-42K	-332K	-2.49M	-572K	-3.41M	-6.62M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-248.22M	-143.04M	-134.53M	-103.15M	-158.31M	-401.99M
Sales Maturities Of Investments	142.98M	155.65M	102.81M	158.02M	286.2M	419.26M
Other Investing Acitivies	n/a	n/a	1.51M	1.1B	6K	64K
Investing Cash Flow	-105.28M	12.28M	-32.7M	1.15B	124.49M	10.72M
Debt Repayment	n/a	n/a	n/a	-631.6M	-10.73M	144.65M
Common Stock Repurchased	-4.03M	-3.1M	-199.55M	-132.28M	-9.06M	-9.75M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	508K	618K	5.08M	3.47M	-11.73M
Financial Cash Flow	-3.25M	-2.5M	-198.93M	-758.81M	91.86M	263.09M
Net Cash Flow	130.01M	-1.75M	-258.63M	208.21M	8.5M	23.4M
Free Cash Flow	238.5M	-11.87M	-29.49M	-187.56M	-211.26M	-257.02M
Adj. Free Cash Flow	220.02M	-33.26M	-54.86M	-227.3M	-273.33M	-320M
Maintenance CapEx	n/a	n/a	n/a	-572K	-3.41M	-6.62M
Growth CapEx	-42K	-332K	-2.49M	n/a	n/a	n/a
Owner Earnings	238.54M	-11.54M	-27M	-187.56M	-211.26M	-257.02M